Mankind Pharma has been assigned an Environmental, Social, and Governance (ESG) Rating of ‘64.8’ (Grade B) (Adjusted) by SES ESG Research Private Limited. The rating was assigned in a report dated November 27, 2025. Mankind Pharma clarifies they did not engage SES for this rating, which was independently assigned based on publicly available information.
ESG Rating Update
Mankind Pharma has received an Environmental, Social, and Governance (ESG) rating from SES ESG Research Private Limited (“SES”). The assigned ESG Rating is ‘64.8’ (Grade B) (Adjusted). This information was disclosed on November 28, 2025.
Rating Details
The ESG rating was assigned by SES in a report dated November 27, 2025. Mankind Pharma stated that it did not engage SES for the rating. The rating was independently assigned by SES for FY 2024-25, based on publicly available data.
Source: BSE
